Editorial: Commercialization and industrialization of pharmacology of infectious diseases: 2022

Affiliations

Yanqin Huang: Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, United States
Yanqin Huang: Harvard Medical School, Boston, MA, United States
Sue C. Nang: Department of Microbiology, Biomedicine Discovery Institute, Monash University, Melbourne, VIC, Australia
Yu-Wei Lin: Department of Microbiology, Biomedicine Discovery Institute, Monash University, Melbourne, VIC, Australia
Yu-Wei Lin: Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia
Yu-Wei Lin: Malaya Translational and Clinical Pharmacometrics Group, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur, Malaysia
Yu-Wei Lin: Department of Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur, Malaysia
Yu-Wei Lin: Certara Drug Development Solutions, Certara, Radnor, PA, United States
Fekade Sime: Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia

Abstract

No abstracts available.